This is a snippet of the transcript, sign up to read more.
It could pose a significant risk for Lifco if Henry Schein were to enter the market. However, Lifco is more than just dental today. It's driven by highly committed individuals, which I believe is Lifco's greatest strength.
This is a snippet of the transcript, sign up to read more.
It was strategic not to create margin in different steps. In this case, it's full transparency because if you buy a product for 50 Swedish krona, then this product is sold to the sales company for 50 Swedish krona upon delivery. No extra charge for that. This allows the sales company to measure their own margins in separate sales and better monitor how their pricing affects the result.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.